Common subtle signs of cervical cancer are abnormal bleeding. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cervix Uteri Cell Line, Tumor Tumor Cells, Cultured HeLa Cells Pelvis Neoplastic Stem Cells Breast

Organisms5

Papillomaviridae Human papillomavirus 16 Human papillomavirus 18 Alphapapillomavirus Mice, Nude

Diseases43

Uterine Cervical Neoplasms Papillomavirus Infections Cervical Intraepithelial Neoplasia Carcinoma, Squamous Cell Breast Neoplasms Neoplasms Neoplasm Invasiveness Ovarian Neoplasms Prostatic Neoplasms Tumor Virus Infections Lung Neoplasms Adenocarcinoma Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Carcinoma Disease Progression Pancreatic Neoplasms Carcinoma, Adenosquamous Genital Neoplasms, Female Uterine Cervical Dysplasia Precancerous Conditions Genetic Predisposition to Disease Colorectal Neoplasms Cell Transformation, Neoplastic Neoplasm Recurrence, Local Endometrial Neoplasms Carcinoma in Situ Urinary Bladder Neoplasms Vaginal Neoplasms Carcinoma, Non-Small-Cell Lung Rectal Neoplasms Neoplasms, Squamous Cell Esophageal Neoplasms Neoplasms, Second Primary Mouth Neoplasms Pregnancy Complications, Neoplastic Neoplasms, Radiation-Induced Head and Neck Neoplasms Neovascularization, Pathologic Lymphatic Metastasis Skin Neoplasms Liver Neoplasms

Chemicals and Drugs28

Papillomavirus Vaccines Oncogene Proteins, Viral Papillomavirus E7 Proteins Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cancer Vaccines RNA, Messenger Tumor Suppressor Protein p53 DNA, Viral Cisplatin Receptors, Estrogen DNA, Neoplasm Receptor, erbB-2 RNA, Small Interfering Repressor Proteins Prostate-Specific Antigen Antigens, Neoplasm Antineoplastic Agents, Phytogenic Tamoxifen Receptors, Progesterone Paclitaxel Antineoplastic Agents, Hormonal Fluorouracil MicroRNAs DNA-Binding Proteins Tumor Suppressor Proteins Anticarcinogenic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment59

Vaginal Smears Early Detection of Cancer Papanicolaou Test Mass Screening Neoplasm Staging Prognosis Hysterectomy Risk Factors Incidence Colposcopy Survival Rate Follow-Up Studies Survival Analysis Registries Sensitivity and Specificity Retrospective Studies Combined Modality Therapy Risk Polymerase Chain Reaction Mammography Prospective Studies Brachytherapy Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Questionnaires Risk Assessment Antineoplastic Combined Chemotherapy Protocols Odds Ratio Disease-Free Survival Immunohistochemistry Treatment Outcome Xenograft Model Antitumor Assays Blotting, Western Logistic Models Neoplasm Transplantation Chemotherapy, Adjuvant Radiotherapy Multivariate Analysis SEER Program Oligonucleotide Array Sequence Analysis Predictive Value of Tests Neoplasm Grading Case-Control Studies Tumor Burden Transplantation, Heterologous Cohort Studies Lymph Node Excision Kaplan-Meier Estimate Biopsy Clinical Trials as Topic Radiotherapy Dosage Prevalence Reproducibility of Results Pelvic Exenteration Cross-Sectional Studies Drug Screening Assays, Antitumor Confidence Intervals Chemoradiotherapy Models, Biological

Psychiatry and Psychology2

Health Knowledge, Attitudes, Practice Smoking

Phenomena and Processes27

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Risk Genetic Predisposition to Disease Mutation Odds Ratio Cell Proliferation DNA Methylation Apoptosis Drug Resistance, Neoplasm Genotype Down-Regulation Time Factors Genes, BRCA1 Polymorphism, Genetic Cell Survival Genes, p53 Cell Cycle Cell Movement Promoter Regions, Genetic Cell Division Signal Transduction Genes, Tumor Suppressor Gene Silencing Oncogenes RNA Interference Dose-Response Relationship, Drug

Disciplines and Occupations3

Medical Oncology Immunohistochemistry Gynecology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Age Distribution

Information Science6

Incidence Survival Rate Registries Questionnaires SEER Program Prevalence

Named Groups1

Health Care33

Mass Screening Risk Factors Incidence Survival Rate Follow-Up Studies Survival Analysis Age Factors Registries Sensitivity and Specificity Retrospective Studies Risk Health Knowledge, Attitudes, Practice Prospective Studies Questionnaires Risk Assessment Odds Ratio Disease-Free Survival Treatment Outcome Logistic Models Multivariate Analysis SEER Program Predictive Value of Tests Patient Acceptance of Health Care Case-Control Studies Cohort Studies Kaplan-Meier Estimate Clinical Trials as Topic Prevalence Reproducibility of Results Cross-Sectional Studies National Cancer Institute (U.S.)Confidence Intervals Age Distribution

Geographicals5

United States Appalachian Region China Thailand Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Uterine Cervical Neoplasms Papillomavirus Infections Papillomavirus Vaccines Papillomaviridae Vaginal Smears Early Detection of Cancer Papanicolaou Test Cervical Intraepithelial Neoplasia Human papillomavirus 16 Mass Screening Carcinoma, Squamous Cell Breast Neoplasms Human papillomavirus 18 Neoplasms Neoplasm Invasiveness Cervix Uteri Alphapapillomavirus Oncogene Proteins, Viral Ovarian Neoplasms Neoplasm Staging Papillomavirus E7 Proteins Prostatic Neoplasms Prognosis Gene Expression Regulation, Neoplastic Tumor Virus Infections Lung Neoplasms Adenocarcinoma Hysterectomy Cell Line, Tumor Risk Factors Tumor Markers, Biological Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Carcinoma Incidence Antineoplastic Agents Colposcopy Neoplasm Proteins Mice, Nude Survival Rate Disease Progression Follow-Up Studies Survival Analysis Age Factors Registries Pancreatic Neoplasms United States Sensitivity and Specificity Retrospective Studies Carcinoma, Adenosquamous Cancer Vaccines Genital Neoplasms, Female Uterine Cervical Dysplasia Combined Modality Therapy Risk Precancerous Conditions Genetic Predisposition to Disease Polymerase Chain Reaction Health Knowledge, Attitudes, Practice Colorectal Neoplasms Mammography Prospective Studies Cell Transformation, Neoplastic Neoplasm Recurrence, Local Brachytherapy Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Questionnaires Endometrial Neoplasms Risk Assessment Mutation Antineoplastic Combined Chemotherapy Protocols RNA, Messenger Tumor Suppressor Protein p53 Survivors Odds Ratio DNA, Viral Cisplatin Carcinoma in Situ Disease-Free Survival Cell Proliferation DNA Methylation Apoptosis Drug Resistance, Neoplasm Genotype Receptors, Estrogen Smoking DNA, Neoplasm Medical Oncology Urinary Bladder Neoplasms Immunohistochemistry Receptor, erbB-2 Treatment Outcome Xenograft Model Antitumor Assays Blotting, Western Logistic Models Neoplasm Transplantation Vaginal Neoplasms Chemotherapy, Adjuvant

No FAQ available that match "common subtle signs of cervical cancer are abnormal bleeding"